
News
CAR T-Cell Therapy Market to Reach US$24 Bn by 2032 at 25% CAGR, Says Persistence Market Resaerch
The CAR T-cell therapy market is one of the most rapidly expanding sectors in the biopharmaceutical industry, driven by significant advancements in gene-editing technology, regulatory
